Bank of America
LENZ

Bank of America’s LENZ Therapeutics LENZ Stock Holding History

Bank of America’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.01M Buy
547,534
+432,846
+377% +$6.08M ﹤0.01% 3468
2025
Q4 		$1.84M Sell
114,688
-234,440
-67% -$6.83M ﹤0.01% 4128
2025
Q3 		$16.3M Buy
349,128
+281,150
+414% +$10.3M ﹤0.01% 2807
2025
Q2 		$1.99M Buy
67,978
+49,653
+271% +$1.35M ﹤0.01% 4775
2025
Q1 		$471K Sell
18,325
-19,921
-52% -$491K ﹤0.01% 5682
2024
Q4 		$1.1M Buy
38,246
+18,395
+93% +$561K ﹤0.01% 4949
2024
Q3 		$471K Buy
19,851
+3,143
+19% +$69.8K ﹤0.01% 5516
2024
Q2 		$289K Buy
16,708
+12,781
+325% +$223K ﹤0.01% 5687
2024
Q1 		$87.7K Sell
3,927
-5,038
-56% -$105K ﹤0.01% 6299
2023
Q4 		$164K Buy
8,965
+319
+4% +$5.27K ﹤0.01% 6179
2023
Q3 		$150K Sell
8,646
-701
-7% -$12.2K ﹤0.01% 6062
2023
Q2 		$170K Sell
9,347
-1,502
-14% -$30K ﹤0.01% 5945
2023
Q1 		$186K Buy
10,849
+3,343
+45% +$54.1K ﹤0.01% 5959
2022
Q4 		$174K Buy
7,506
+2,114
+39% +$49K ﹤0.01% 5983
2022
Q3 		$120K Buy
5,392
+125
+2% +$2.98K ﹤0.01% 6257
2022
Q2 		$101K Sell
5,267
-3,906
-43% -$87.1K ﹤0.01% 6459
2022
Q1 		$328K Sell
9,173
-297
-3% -$18.6K ﹤0.01% 6119
2021
Q4 		$824K Buy
9,470
+5,111
+117% +$423K ﹤0.01% 5456
2021
Q3 		$500K Buy
4,359
+4,330
+14,931% +$641K ﹤0.01% 5639
2021
Q2 		$6K Buy
+29
New +$5.05K ﹤0.01% 7406

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Bank of America's LENZ Position: Q1 2026 in Review

Bank of America increased its LENZ Therapeutics (LENZ) stake by 377% in Q1 2026, buying an estimated $6.08M and bringing the position to 547,534 shares worth $5.01M. The position accounts for ﹤0.01% of the portfolio, ranked #3468.

Bank of America first reported a position in LENZ in Q2 2021 and has held it in 20 quarters since. The position peaked at $16.3M in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Bank of America held 547,534 shares of LENZ Therapeutics worth $5.01M as of Q1 2026.
  • Bank of America bought 432,846 LENZ Therapeutics shares in Q1 2026, an estimated $6.08M.
  • LENZ Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3468 holding.
  • Bank of America first reported a position in LENZ Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Bank of America's LENZ Therapeutics position peaked at $16.3M in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.